Pharmaceutical Companies

For MSD, this acquisition is part of a broader strategy to diversify its pipeline before its blockbuster immunotherapy Keytruda loses patent protection.

Avlayah’s approval validates Denali’s blood-brain barrier shuttle technology, which the company now applies across five clinical programs targeting Alzheimer’s disease, Parkinson’s disease, and Sanfilippo syndrome type A, among others.

The 460,000-square-foot factory will sit on a 79-acre plot within the Rowen innovation district, near Dacula, Georgia, approximately 35 miles northeast of downtown Atlanta.

This building will accommodate up to 250 researchers and provides a collaborative workspace with modular laboratories designed to support both growth and interdisciplinary exchange.

Construction is expected to be complete by the third quarter of 2027, at which point the site’s workforce is also set to double.

Wegovy HD became the fourth drug to receive FDA approval through the Commissioner’s National Priority Voucher pilot programme.

The companies are competing for a share of India’s Semaglutide market, which analysts estimate will reach USD1 billion over the next two years.

Psoriasis is a chronic autoimmune disorder in which skin cells multiply excessively, creating thick, itchy, scaly patches that affect more than 8 million Americans.

Novartis will direct the funds toward upgrading its manufacturing plant in Beijing and expanding its R&D campus in Shanghai, where it also houses its Chinese headquarters.